177 related articles for article (PubMed ID: 2784357)
1. Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia. Characterization of the antibody, in vitro effector functions and results of therapy.
Janson CH; Tehrani MJ; Mellstedt H; Wigzell H
Cancer Immunol Immunother; 1989; 28(3):225-32. PubMed ID: 2784357
[TBL] [Abstract][Full Text] [Related]
2. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
Powell TJ; Spann R; Nguyenduc M; Lamon EW
J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
[TBL] [Abstract][Full Text] [Related]
3. Modulation by antiidiotypic monoclonal antibodies of immune lysis mediated by anti-HLA monoclonal antibodies.
Ono R; Sakaguchi K; Ferrone S
J Immunol; 1989 Sep; 143(6):1921-9. PubMed ID: 2528584
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against idiotypic determinant(s) of the T cell receptor from HPB-ALL cells induce IL2 production in Jurkat cells without apparent evidence of binding.
Carrel S; Giuffrè L; Vacca A; Salvi S; Mach JP; Isler P
Eur J Immunol; 1986 Jul; 16(7):823-8. PubMed ID: 3522247
[TBL] [Abstract][Full Text] [Related]
5. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
Cancer Immunol Immunother; 1994 Mar; 38(3):149-59. PubMed ID: 8124683
[TBL] [Abstract][Full Text] [Related]
6. Human T cell lines differing in phenotype and specificity are reactive with the same anti-idiotypic antibody.
Borst J; Boylston AW; de Vries JE; Spits H
J Immunol; 1986 Jan; 136(2):601-8. PubMed ID: 2416817
[TBL] [Abstract][Full Text] [Related]
7. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
Qian GX; Fu SM; Solanki DL; Rai KR
J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
[TBL] [Abstract][Full Text] [Related]
8. The targeting of CD4+ T lymphocytes to a B cell lymphoma. A comparison of anti-CD3-anti-idiotype antibody conjugates and antigen-anti-idiotype antibody conjugates.
Gravelle M; Ochi A
J Immunol; 1989 Jun; 142(11):4079-84. PubMed ID: 2523940
[TBL] [Abstract][Full Text] [Related]
9. Idiotypic analysis of anti-I-Ak monoclonal antibodies. III. T- and B-cell responses to anti-Ia idiotopes are not modulated by syngeneic anti-idiotypic monoclonal antibodies.
Phillips ML; Delovitch TL
Cell Immunol; 1985 Dec; 96(2):363-75. PubMed ID: 3879805
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.
Barel M; Fiandino A; Delcayre AX; Lyamani F; Frade R
J Immunol; 1988 Sep; 141(5):1590-5. PubMed ID: 2842398
[TBL] [Abstract][Full Text] [Related]
12. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
13. Syngeneic anti-idiotypes against monoclonal anti-HLA-DR antibodies: characterization of recurrent idiotopes.
Piatier-Tonneau D; Boyer B; Debre P; Charron DJ
J Immunol; 1983 Sep; 131(3):1339-43. PubMed ID: 6193186
[TBL] [Abstract][Full Text] [Related]
14. Idiotypic analysis of anti-I-Ak monoclonal antibodies. II. Detection of shared idiotopes on syngeneic BALB/c and allogeneic A.TH-derived anti-I-Ak mAb by BALB/c-derived anti-I-Ak anti-idiotypic mAb.
Devaux CA; Phillips ML; Delovitch TL
J Immunol; 1984 Nov; 133(5):2595-602. PubMed ID: 6207236
[TBL] [Abstract][Full Text] [Related]
15. Titration calorimetry study of an anti-idiotypic antibody cascade in a human melanoma-associated antigen system.
Mutz M; Hawthorne T; Ferrone S; Pluschke G
Mol Immunol; 1997 Jul; 34(10):695-707. PubMed ID: 9430197
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
17. Characterization of "regulatory" idiotope-specific T cell clones to a monoclonal anti-idiotypic antibody mimicking a tumor-associated antigen (TAA).
Saeki Y; Chen JJ; Shi LF; Raychaudhuri S; Köhler H
J Immunol; 1989 Feb; 142(3):1046-52. PubMed ID: 2783599
[TBL] [Abstract][Full Text] [Related]
18. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
Weiner GJ; Hillstrom JR
J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
[TBL] [Abstract][Full Text] [Related]
19. Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody.
Herlyn D; Lubeck M; Sears H; Koprowski H
J Immunol Methods; 1985 Dec; 85(1):27-38. PubMed ID: 3878375
[TBL] [Abstract][Full Text] [Related]
20. Growth of normal human T lymphocytes induced by monoclonal antibody to the T cell antigen receptor.
Boylston AW; Cosford P
Eur J Immunol; 1985 Jul; 15(7):738-42. PubMed ID: 3874082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
